Published in Physiology (Bethesda) on March 01, 2015
Central-peripheral neural network interactions evoked by vagus nerve stimulation: functional consequences on control of cardiac function. Am J Physiol Heart Circ Physiol (2015) 0.91
Renal denervation for the treatment of resistant hypertension: review and clinical perspective. Am J Physiol Renal Physiol (2015) 0.88
Central Angiotensin-II Increases Blood Pressure and Sympathetic Outflow via Rho Kinase Activation in Conscious Rabbits. Hypertension (2016) 0.76
Preeclampsia and the brain: neural control of cardiovascular changes during pregnancy and neurological outcomes of preeclampsia. Clin Sci (Lond) (2016) 0.75
Regulation of the renal sympathetic nerves in heart failure. Front Physiol (2015) 0.75
Impact of global versus renal-specific sympathoinhibition in aldosterone-induced hypertension: implications for medical device-based treatment of resistant hypertension. Hypertension (2015) 0.75
Cardiac and peripheral autonomic control in restrictive cardiomyopathy. ESC Heart Fail (2017) 0.75
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet (2010) 14.40
Neural control of renal function. Physiol Rev (1997) 4.00
Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol (2011) 3.08
Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev (2010) 2.74
Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity? Hypertension (2005) 2.48
Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension (2006) 2.41
Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension (2010) 2.38
Long-term control of arterial blood pressure. Physiol Rev (1992) 2.29
Baroreceptors and the long-term control of blood pressure. Exp Physiol (2004) 2.26
Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension. Hypertension (2005) 2.23
Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation (2012) 2.07
Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med (1999) 2.03
Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension (1988) 1.99
Systemic and renal-specific sympathoinhibition in obesity hypertension. Hypertension (2011) 1.97
What sets the long-term level of renal sympathetic nerve activity: a role for angiotensin II and baroreflexes? Circ Res (2003) 1.91
Prolonged activation of the baroreflex produces sustained hypotension. Hypertension (2004) 1.86
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010) 1.82
Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure. Hypertension (2006) 1.36
Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension (2009) 1.33
Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension (2000) 1.28
The autonomic nervous system and hypertension. Circ Res (2014) 1.28
Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex. Am J Physiol Heart Circ Physiol (2010) 1.24
Baroreceptor denervation prevents sympathoinhibition during angiotensin II-induced hypertension. Hypertension (2005) 1.24
Recent insights into the interactions between the baroreflex and the kidneys in hypertension. Am J Physiol Regul Integr Comp Physiol (2005) 1.23
Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension (2007) 1.21
Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens (2012) 1.20
Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens (2012) 1.19
Brain stem control of arterial pressure in chronic arterial baroreceptor-denervated rats. Am J Physiol Regul Integr Comp Physiol (2005) 1.19
Baroreflexes prevent neurally induced sodium retention in angiotensin hypertension. Am J Physiol Regul Integr Comp Physiol (2000) 1.15
Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy. Hypertension (2011) 1.15
Selective contribution of two types of carotid sinus baroreceptors to the control of blood pressure. Circ Res (1993) 1.12
Differential frequency-dependent reflex integration of myelinated and nonmyelinated rat aortic baroreceptors. Am J Physiol (1998) 1.12
What does the brain know about blood pressure? News Physiol Sci (2001) 1.11
Prolonged activation of the baroreflex decreases arterial pressure even during chronic adrenergic blockade. Hypertension (2009) 1.09
Lowering of blood pressure during chronic suppression of central sympathetic outflow: insight from computer simulations. Clin Exp Pharmacol Physiol (2009) 1.07
Neurons of the rostral ventrolateral medulla contribute to obesity-induced hypertension in rats. Hypertension (2006) 1.05
Effects of chronic baroreceptor unloading on blood pressure in the dog. Am J Physiol Regul Integr Comp Physiol (2004) 1.05
Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure. Circ Heart Fail (2010) 1.03
Chronic angiotensin II infusion decreases renal norepinephrine overflow in conscious dogs. Hypertension (1984) 1.01
Nucleus tractus solitarius and control of blood pressure in chronic sinoaortic denervated rats. Am J Physiol (1992) 0.99
Effect of sino-aortic denervation in comparison to cardiopulmonary deafferentiation on long-term blood pressure in conscious dogs. Pflugers Arch (1988) 0.98
Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens (1998) 0.98
Renal responses to chronic suppression of central sympathetic outflow. Hypertension (2012) 0.96
The blood pressure buffering capacity of nitric oxide by comparison to the baroreceptor reflex. Am J Physiol (1994) 0.94
Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotension-induced hypertension in dogs. Circ Res (1976) 0.93
Characteristics of aortic baroreceptors with non-medullated afferents arising from the aortic arch of rabbits with chronic renovascular hypertension. Acta Physiol Scand (1977) 0.92
Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension: results from European and United States trials of the Rheos system. J Am Coll Cardiol (2011) 0.90
Chronic baroreflex activation restores spontaneous baroreflex control and variability of heart rate in obesity-induced hypertension. Am J Physiol Heart Circ Physiol (2013) 0.89
Afferent signaling drives oxytocinergic preautonomic neurons and mediates training-induced plasticity. Am J Physiol Regul Integr Comp Physiol (2011) 0.88
Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension. Hypertension (2013) 0.87
Resetting of pressure-dependent renin release by intrarenal alpha 1-adrenoceptors in conscious dogs. Pflugers Arch (1989) 0.86
Threshold pressure for the pressure-dependent renin release in the autoregulating kidney of conscious dogs. Pflugers Arch (1983) 0.86
Sustained activation of the central baroreceptor pathway in angiotensin hypertension. Hypertension (2002) 0.86
Acute resetting in two functionally different types of carotid baroreceptors. Circ Res (1992) 0.86
Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction. J Card Fail (2010) 0.85
Lowering of blood pressure by chronic suppression of central sympathetic outflow: insight from prolonged baroreflex activation. J Appl Physiol (1985) (2012) 0.84
Influence of GABA in the nucleus of the solitary tract on blood pressure in baroreceptor-denervated rats. Am J Physiol (1997) 0.83
Sustained influence of the renal nerves to attenuate sodium retention in angiotensin hypertension. Am J Physiol Regul Integr Comp Physiol (2001) 0.82
Baroreflex activation: from mechanisms to therapy for cardiovascular disease. Curr Hypertens Rep (2014) 0.81
Sustained activation of the central baroreceptor pathway in obesity hypertension. Hypertension (2003) 0.81
The sympathetic nervous system in obesity hypertension. Curr Hypertens Rep (2013) 0.80
Blood pressure regulation in baroreceptor-denervated rats. Clin Exp Pharmacol Physiol (1997) 0.77
Systemic vascular effects of acute electrical baroreflex stimulation. Am J Physiol Heart Circ Physiol (2014) 0.76
Renal denervation supersensitivity revisited. Am J Physiol (1998) 0.76
Effects of electrical stimulation of the carotid sinus baroreflex using the Rheos device on ventricular-vascular coupling and myocardial efficiency assessed by pressure-volume relations in non-vagotomized anesthetized dogs. Conf Proc IEEE Eng Med Biol Soc (2009) 0.76